INTERNATIONAL PATENT: SHANGHAI SCIZENG MEDICAL TECHNOLOGY CO., LTD., 上海赛增医疗科技有限公司 FILES APPLICATION FOR "SINGLE-DOMAIN ANTIBODY TARGETING SERUM ALBUMIN AND FUSION PROTEIN"

GENEVA, Nov. 10 -- SHANGHAI SCIZENG MEDICAL TECHNOLOGY CO., LTD. (Floor 3, No. 1, Lane 100, Banxia RoadPudong New Area, Shanghai 201318), 上海赛增医疗科技有限公司 (中国上海市浦东新区半夏路100弄1号第3层) filed a patent application (PCT/CN2025/091702) for "SINGLE-DOMAIN ANTIBODY TARGETING SERUM ALBUMIN AND FUSION PROTEIN" on Apr 28, 2025. With publication no. WO/2025/228322, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by th...